-- Diluted EPS of $1.36; Adjusted Diluted EPS of $1.62 ---- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $1.62 in the third quarter of 2024. Premium and service revenues of $36.9 billion in the third quarter of 2024. Membership increases of 22% in Marketplace and 49% in Medicare Prescription Drug Plans, compared to the third quarter of 2023. Continued execution on capital deployment with $1.2 billion of share repurchases during the third quarter of 2024 ...